Clinical Trials: Find a Clinical Trial

At any time Memorial Sloan-Kettering Cancer Center is conducting hundreds of clinical trials to improve care for many types of cancer. Use the tool below to browse our clinical trials that are currently enrolling new patients. Each listing explains the purpose of the trial, the trial’s eligibility criteria, and how to get more information.

The list below includes clinical trials for adult cancers. Please visit our pediatric cancer care section to find a pediatric clinical trial.

Showing 221 - 240 of 449 trials
Titlesort icon Investigator Disease(s)
A Phase II Study of Paclitaxel, Trastuzumab, and Pertuzumab for the Treatment of Metastatic HER2-Positive Breast Cancer
[Protocol 10-142]
Dang, Chau
  • Breast Cancer
A Phase II Study of Palifermin with or without Leuprolide After T-Cell-Depleted Allogeneic Stem Cell Transplantation
[Protocol 12-077]
Goldberg, Jenna
  • Blood & Marrow Stem Cell Transplantation
    • Post-Transplant
  • Hematology
    • Myelodysplastic Syndrome
  • Leukemia
    • Acute Lymphoblastic Leukemia
    • Acute Myelocytic Leukemia
    • Acute Myelogenous Leukemia
    • Chronic Myelocytic Leukemia
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase II Study of Partial Breast Irradiation for Select Patients with Early Invasive or Noninvasive Breast Cancer
[Protocol 10-114]
Powell, Simon
  • Breast Cancer
A Phase II Study of PD0332991 in Patients with Advanced or Metastatic Liposarcoma
[Protocol 10-094]
Dickson, Mark
  • Sarcomas
    • Soft Tissue Sarcoma
A Phase II Study of Peri-transplant Palifermin followed by an Allogeneic T-Cell-Depleted Stem Cell Transplant in Patients with Advanced Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML) Evolved from MDS
[Protocol 08-008]
Castro-Malaspina, Hugo
  • Blood & Marrow Stem Cell Transplantation
    • Sibling and Unrelated Volunteer
  • Blood and Marrow Transplantation
    • Transplantation
  • Hematology
    • Myelodysplastic Syndrome
  • Leukemia
    • Acute Myelogenous Leukemia
A Phase II Study of PET Scan-Directed Combined Modality Therapy for Esophageal Cancer
[Protocol 12-011]
Ilson, David
  • Upper Gastrointestinal
    • Esophageal Cancer
A Phase II Study of Pomalidomide plus Autologous Stem Cell Transplantation versus Pomalidomide/Dexamethasone in Patients with Multiple Myeloma
[Protocol 12-138]
Giralt, Sergio
  • Hematology
    • Multiple Myeloma
A Phase II Study of Quizartinib in Patients with FLT3-ITD-Positive Relapsed or Refractory Acute Myeloid Leukemia
[Protocol 12-106]
Tallman, Martin
  • Leukemia
    • Acute Myelocytic Leukemia
    • Acute Myelogenous Leukemia
A Phase II Study of RAD001 (Everolimus) and Pasireotide (SOM230)) in Patients with Advanced Uveal Melanoma
[Protocol 10-123]
Carvajal, Richard
  • Melanoma
    • Melanoma of the Eye
A Phase II Study of Reduced-Intensity Allogeneic Stem Cell Transplant for High-Risk Chronic Lymphocytic Leukemia
[Protocol 11-024]
Perales, Miguel-Angel
  • Blood and Marrow Transplantation
    • Transplantation
  • Leukemia
    • Chronic Lymphocytic Leukemia
A Phase II Study of Repeat Breast-Preserving Surgery and 3D-Conformal Partial Breast Re-Irradiation for Local Recurrence of Breast Cancer
[Protocol 10-152]
McCormick, Beryl
  • Breast Cancer
A Phase II Study of Response-Based Radiation Therapy for Patients with Localized Germ Cell Tumors of the Central Nervous System
[Protocol 12-243]
Dunkel, Ira
  • Germ Cell Tumors
  • Pediatric Brain Tumors
    • CNS Cancer
A Phase II Study of Secondary Cytoreduction with and without HIPEC plus Postoperative Chemotherapy for Women with Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
[Protocol 12-275]
Chi, Dennis
  • Ovarian Cancer
A Phase II Study of Siltuximab in Patients with High-Risk Smoldering Multiple Myeloma
[Protocol 12-068]
Lesokhin, Alexander
  • Hematology
    • Multiple Myeloma
A Phase II Study of Sorafenib in Children and Young Adults with Relapsed/Refractory Rhabdomyosarcoma, Wilms Tumor, Hepatocellular Carcinoma, or Papillary Thyroid Cancer
[Protocol 12-139]
Trippett, Tanya
  • Hepatobiliary
    • Liver Cancer
  • Kidney Cancer
  • Sarcomas
    • Rhabdomyosarcoma
  • Thyroid Cancer
A Phase II Study of Sorafenib plus Doxorubicin in Patients with Liver Cancer that Continued Growing with Sorafenib Therapy
[Protocol 12-259]
Abou-Alfa, Ghassan
  • Hepatobiliary
    • Liver Cancer
A Phase II Study of Sunitinib or Cediranib for Inoperable Metastatic Alveolar Soft Part Sarcoma
[Protocol 12-095]
Keohan, Mary
  • Sarcomas
    • Soft Tissue Sarcoma
A Phase II Study of Sunitinib to Treat High-Grade Glioma and Ependymoma Tumors in Pediatric and Young Adult Patients
[Protocol 13-026]
Khakoo, Yasmin
  • Brain Tumors, Primary
    • Gliomas
    • Other Trials
  • Pediatric Brain Tumors
    • Brain Cancer
A Phase II Study of Temozolomide Alone or with ABT-888 (Veliparib) in Patients with Relapsed or Refractory Small Cell Lung Cancer
[Protocol 12-021]
Pietanza, M. Catherine
  • Lung Cancer
  • Lung Cancer, Small Cell
    • Other
A Phase II Study of Temozolomide plus Irinotecan with or without Bevacizumab in Children with Recurrent or Refractory Medulloblastoma or PNET
[Protocol 11-089]
De Braganca, Kevin
  • Pediatric Brain Tumors
    • Brain Cancer